ReviewInternational journal of clinical oncology2012
Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.
Review in International journal of clinical oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 27 citations in OpenAlex.
- Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.The European respiratory journal · 2017Trial
- CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review.Journal of thoracic disease · 2026Article
- Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study.Frontiers in oncology · 2025Article
- 18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma.Medicine · 2021Article
- Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patients.World journal of radiology · 2021Article
- Chest-CT mimics of COVID-19 pneumonia-a review article.Emergency radiology · 2021Review
- Review
- [The Effects and Management of Viral Pneumonia on Lung Cancer Patients].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Review
- Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib.Internal medicine (Tokyo, Japan) · 2020Article
- [Noninfectious differential diagnoses of pneumonia].Der Radiologe · 2017Review
- Targeting precision medicine toxicity: recent developments.Therapeutic advances in drug safety · 2015Article
- Clinical analysis of chronic lung injury in patients with non-Hodgkin lymphoma after CHOP chemotherapy.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced lung injury (DLI) comprises a wide variety of pathologies, each with a unique imaging pattern, so there are no characteristic imaging findings to establish diagnosis. When DLI is suspected, evaluation must exclude progression of underlying disease, infection, and mimicking diseases. Correct diagnosis requires integration of clinical information and radiologic, laboratory, and pathological findings when available. We describe the radiologic findings of DLI, the roles of the findings in the management of patients with DLI, and the limitations of radiologic diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.